Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2012
08/08/2012CN101328484B Delta-endotoxin genes and methods for their use
08/08/2012CN101137670B Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody
08/08/2012CN101087877B Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody
08/07/2012USRE43568 Anti-P-selectin antibodies
08/07/2012US8236934 complexing of multiple antigens or proteins in a controlled, multivariable fashion, to one single primary recombinant monoclonal antibody; activate dendritic cells and other cells; bound to one half of a Coherin/Dockerin pair
08/07/2012US8236933 Modified animal lacking functional PYY gene, monoclonal antibodies that bind PYY isoforms and uses therefor
08/07/2012US8236932 High affinity antibodies that neutralize Staphylococcus enterotoxin B
08/07/2012US8236931 Prevention of aggregation of immunoglobulin light or heavy chains
08/07/2012US8236930 Binding molecules to the human OX40 receptor
08/07/2012US8236928 Genes differentially expressed in breast cancer
08/07/2012US8236925 Protein nanorings
08/07/2012US8236774 Human telomerase catalytic subunit
08/07/2012US8236762 Peptide-cytotoxic conjugates
08/07/2012US8236753 RAP variants for drug delivery and methods of use thereof
08/07/2012US8236559 Therapeutic human anti-IL-1R1 monoclonal antibody
08/07/2012US8236530 Method for preparing monoclonal antibody
08/07/2012US8236510 Protein showing enhanced expression in cancer cells
08/07/2012US8236487 Tumor specific oligosaccharide sequences and use thereof
08/07/2012US8236325 S. epidermidis antigens
08/07/2012US8236324 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection
08/07/2012US8236319 Cross-linkers and their uses
08/07/2012US8236317 Methods of treating with anti-factor D antibodies
08/07/2012US8236312 VEGF-specific human antibody
08/07/2012US8236311 Antibodies against clostridium difficile toxins and uses thereof
08/07/2012US8236310 Antibodies and related molecules that bind to 161P2F10B proteins
08/07/2012US8236309 Use of bispecific antibodies to regulate immune responses
08/07/2012US8236307 Humanized anti-FGF19 antagonists and methods using same
08/07/2012US8236305 Antibodies that bind PAR-2
08/07/2012CA2525961C Targeted biocides
08/07/2012CA2457414C Virus coat protein/receptor chimeras and methods of use
08/07/2012CA2456516C Identification of a dna variant associated with adult type hypolactasia
08/07/2012CA2447367C Diagnosis and treatment of malignant neoplasms
08/07/2012CA2445421C Von willebrand factor (vwf)-cleaving protease
08/07/2012CA2439202C Detection of microorganisms in liquid hydrocarbon fuel
08/07/2012CA2429384C Concatameric immunoadhesion
08/07/2012CA2420226C Methods for treating demyelinating diseases
08/07/2012CA2411927C Immunization of dairy cattle with gapc protein against streptococcus infection
08/07/2012CA2319715C Breast cancer resistance protein (bcrp) and the dna which encodes it
08/07/2012CA2317721C Novel steroid-activated nuclear receptors and uses therefor
08/07/2012CA2309676C Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
08/07/2012CA2146895C Ctla4/cd28ig hybrid fusion proteins
08/02/2012WO2012103341A1 Treatment of advanced solid stage tumors using anti-erbb3 antibodies
08/02/2012WO2012103324A2 Method for detection of intestinal, and blood-brain barrier permeability and testing materials thereto
08/02/2012WO2012103260A2 High-throughput methods to produce, validate and characterize mmabs
08/02/2012WO2012103165A2 Anti-kit antibodies and uses thereof
08/02/2012WO2012102820A1 System for defining energy field characteristics to illuminate nano-particles used to treat invasive agents
08/02/2012WO2012102679A1 Pathogenic mycobacteria-derived mannose-capped lipoarabinomannan antigen binding proteins
08/02/2012WO2012102521A2 Human anti-cd23 fab antibody and a pharmaceutical composition for treating tumours comprising same
08/02/2012WO2012102171A1 Yeast for transformation and process for producing protein
08/02/2012WO2012102126A1 Anti-il28b antibody and method for assaying il28b using same
08/02/2012WO2012101664A1 Use of at least one p75ntr receptor inhibitor, alone or in association with at least one trka receptor activator, or of at least one trka receptor activator, for the treatment of chronic inflammatory diseases
08/02/2012WO2012101253A1 Pharmaceutical compositions comprising human antibodies to pcsk9
08/02/2012WO2012101252A2 Human antibodies to pcsk9 for use in methods of treating particular groups of subjects
08/02/2012WO2012101251A1 Human antibodies to pcsk9 for use in methods of treatment based on particular dosage regimens
08/02/2012WO2012101125A1 Specific antibodies against human cxcl4 and uses thereof
08/02/2012WO2012100384A1 Humanized anit-egfr antibody l4-h3 and coding gene thereof
08/02/2012WO2012100346A1 Antibodies selective for cells presenting egfr at high density
08/02/2012WO2012100343A1 Engineering of immunoglobulin domains
08/02/2012WO2012078813A3 Novel modulators and methods of use
08/02/2012WO2012076985A3 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
08/02/2012WO2012054654A3 Anti-folate receptor alpha antibody glycoforms
08/02/2012WO2012051498A3 Antibodies that bind amyloid oligomers
08/02/2012WO2012048291A3 Compositions and methods for inhibition of mmp:mmp-substrate interactions
08/02/2012WO2012038820A3 Immunochromatography devices, methods and kits
08/02/2012WO2010110838A3 Antibody constant domain regions and uses thereof
08/02/2012US20120198575 Methods and compositions for determining the purity of chemically synthesized nucleic acids
08/02/2012US20120196922 Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency
08/02/2012US20120196907 Diazonamide Analogs
08/02/2012US20120196359 POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF
08/02/2012US20120196325 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
08/02/2012US20120196297 Mass tags for mass spectrometric analysis of immunoglobulins
08/02/2012US20120196286 Method and apparatus for diagnosing age-related macular degeneration
08/02/2012US20120195926 Methods of improving vaccine immunogenicity
08/02/2012US20120195916 Method of treating cancer by inhibiting trim59 expression or activity
08/02/2012US20120195913 Compositions and methods of use for therapeutic antibodies
08/02/2012US20120195912 Cripto Blocking Antibodies and Uses Thereof
08/02/2012US20120195910 Anti-pcsk9 antibodies and methods of use
08/02/2012US20120195909 Antibodies against a proliferating inducing ligand (april)
08/02/2012US20120195908 Combinatorial therapy
08/02/2012US20120195907 Monoclonal antibodies against the pbp2-a protein and homologous sequences for the treatment of infections by and immunodiagnostics of bacteria of the firmicutes phylum
08/02/2012US20120195905 Targeted binding agents directed to dll4 and uses thereof 524
08/02/2012US20120195904 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES
08/02/2012US20120195902 Compositions and methods for treating renal disease
08/02/2012US20120195901 Compositions and Methods for Binding Lysophosphatidic Acid
08/02/2012US20120195900 Tri-variable domain binding proteins and uses thereof
08/02/2012US20120195899 Immunizing Compositions and Methods of Use
08/02/2012US20120195898 Immunizing Compositions and Methods of Use
08/02/2012US20120195897 Human domain antibodies against components of the human insulin-like growth factor (igf) system
08/02/2012US20120195886 Sodium pump antibody agonists and methods of treating heart disease using the same
08/02/2012US20120195884 Methods and products for evaluating an immune response to a therapeutic protein
08/02/2012US20120195882 lipoparticle comprising a protein and methods of making and using the same
08/02/2012US20120195879 Carrier immunoglobulins and uses thereof
08/02/2012US20120195855 Methods for up-regulating antigen expression in tumors
08/02/2012US20120195852 Vaccines, immunotherapeutics and methods for using the same
08/02/2012US20120195831 Generation, characterization and uses thereof of anti-her3 antibodies
08/02/2012US20120195830 Monoclonal Antibodies Against Claudin-18 For Treatment of Cancer
08/02/2012US20120195829 Methods for identifying targeting domains and method and compositions comprising the same
08/02/2012CA2828194A1 Method for detection of intestinal, and blood-brain barrier permeability and testing materials thereto
08/02/2012CA2825838A1 Human antibodies to pcsk9 for use in methods of treating particular groups of subjects
08/02/2012CA2825778A1 Pharmaceutical compositions comprising human antibodies to pcsk9
1 ... 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 ... 1494